Efficacy and safety of narrowband ultraviolet B therapy in moderate to severe atopic dermatitis
DOI:
https://doi.org/10.66344/jpad.21.2.2011.451Keywords:
Atopic dermatitis, narrowband UVBAbstract
Background Atopic dermatitis is an inflammatory skin disorder with a chronic relapsing course. In troublesome cases of moderate and severe atopic dermatitis, phototherapy can be an effective treatment modality Objective To evaluate the efficacy and safety of narrowband UVB 311nm as a monotherapy in patients with moderate to severe atopic dermatitis. Patients and methods Patients suffering from moderate to severe atopic dermatitis, diagnosed according to criteria described by Hanifin and Rajka between ages of 6-70 were enrolled in the study. Severity of the disease was assessed by using SCORAD score. UVB irradiation was done thrice a week on alternate days. Efficacy was assessed every two weeks by reduction in modified SCORAD score. Results The mean cumulative dose of 25.91 J/cm2 UVB at a wavelength of 311nm was given in a mean of duration 5.2 weeks treatment. Therapy reduced the atopic dermatitis scores from mean 32.2 (range 20.2-45.5) to 14.2 range (6.2-12.4). Conclusion We conclude that narrowband UVB appears to be a promising treatment for AD, but large patient series, different dosing schedules and long- term safety considerations should be carefully evaluated in the futureÂReferences
Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-60.
Abeck D, Schmidt T, Fesq H et al. Long term efficacy of medium dose UVA-1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000; 42: 254-7.
Reynolds NJ, Franklin V, Gray JC et al. Narrowband ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomized controlled trial. Lancet 2001; 357: 2012-6.
Der-petrossian M, Seeber A, Honigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe atopic dermatitis. Br J Dermatol 2000; 142: 39-43.
Legat FJ, Hofer A, Brabek E, Quehenberger Fm keri Hm Wolf P. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003; 139: 223-4.
Grundmann-Kollmann M, Behrens S, Podda M et al. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol 1999; 40: 995-7.
George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993; 128: 49-56.
Hudson-peacock MJ, Diffey BL, Farr PM. Narrow-band UVB phototherapy for severe atopic dermatitis. Br J Dermatol 1996; 135: 332.
Majoie ML, Oldhoff JM, Weelden HV et al. Narrow band ultraviolet B and medium dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2009; 60: 77-84.
Silva SH, Guedes AC, Gontijo B et al. Influence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis. J Eur Acad Dermatol Venereol 2006; 20: 1114-20.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
